Bill > HB2757

This bill modifies provisions related to accessing medical products by allowing pharmacists to dispense an emergency supply of insulin without a current prescription under specific conditions, such as being unable to contact the prescriber and having a record of a recent prescription or determining that withholding the insulin would endanger the patient's health. It also establishes new regulations for pharmacy benefits managers, requiring them to reimburse pharmacies at least the actual acquisition cost of a dispensed drug plus a minimum dispensing fee of fifteen dollars, and sets limits on out-of-pocket costs for patients for prescription insulin drugs, diabetes devices, and epinephrine delivery devices under health insurance plans, capping them at thirty-five dollars for a thirty-day supply of insulin and one hundred dollars for a single diabetes or epinephrine device, with these limits subject to annual adjustments based on inflation. Additionally, the bill mandates a report by November 1, 2026, detailing pricing practices and policy recommendations for insulin, diabetes devices, and epinephrine delivery devices.

https://house.mo.gov/Bill.aspx?bill=HB2757&year=2026&code=R